A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus

Phase 1 Active not recruiting 40 enrolled Eli Lilly and Company

Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate how fasting and stopping the use of tirzepatide affects the amount of food and drink that stays in the stomach after a meal. Ultrasound will be used to check the stomach content after a test meal.

Timeline

Start: 2026-01-14
Primary completion: 2026-11
Completion: 2026-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tirzepatide	Peptide	—	Subcutaneous

A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications